Dynamical Characterization of Antiviral Effects in COVID-19
Mathematical models describing SARS-CoV-2 dynamics and the corresponding immune responses in patients with COVID-19 can be critical to evaluate possible clinical outcomes of antiviral treatments. In this work, based on the concept of virus spreadability in the host, antiviral effectiveness thresholds are determined to establish whether or not a treatment will be able to clear the infection. In addition, the virus dynamic in the host -- including the time-to-peak and the final monotonically decreasing behavior -- is chracterized as a function of the treatment initial time. Simulation results, based on nine real patient data, show the potential clinical benefits of a treatment classification according to patient critical parameters. This study is aimed at paving the way for the different antivirals being developed to tackle SARS-CoV-2..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
arXiv.org - (2020) vom: 31. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abuin, Pablo [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
XAR019653344 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XAR019653344 | ||
| 003 | DE-627 | ||
| 005 | 20230429062659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210104s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)XAR019653344 | ||
| 035 | |a (DE-599)arXiv2012.15585 | ||
| 035 | |a (arXiv)2012.15585 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 510 |q DE-84 | |
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Abuin, Pablo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dynamical Characterization of Antiviral Effects in COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Mathematical models describing SARS-CoV-2 dynamics and the corresponding immune responses in patients with COVID-19 can be critical to evaluate possible clinical outcomes of antiviral treatments. In this work, based on the concept of virus spreadability in the host, antiviral effectiveness thresholds are determined to establish whether or not a treatment will be able to clear the infection. In addition, the virus dynamic in the host -- including the time-to-peak and the final monotonically decreasing behavior -- is chracterized as a function of the treatment initial time. Simulation results, based on nine real patient data, show the potential clinical benefits of a treatment classification according to patient critical parameters. This study is aimed at paving the way for the different antivirals being developed to tackle SARS-CoV-2. | ||
| 700 | 1 | |a Anderson, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Ferramosca, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Hernandez-Vargas, Esteban A. |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez, Alejandro H. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t arXiv.org |g (2020) vom: 31. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:31 |g month:12 |
| 856 | 4 | 0 | |u https://arxiv.org/abs/2012.15585 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XAR | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 31 |c 12 | ||
| 953 | |2 045F |a 510 | ||
| 953 | |2 045F |a 570 | ||